COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Lyndra Therapeutics is a clinical-stage biopharma developing gastric-resident, star-shaped oral dosage forms (LYNX) that provide weekly-or-longer sustained drug release, advancing LYN-005 (weekly risperidone) and other candidates.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
